Stockscreener 앱 받기
50.65
5.15%
2.5216
Scholar Rock Holding Corp 주식(SRRK)의 최신 뉴스
Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - marketscreener.com
SRRK Stock Price, Quote & Chart | SCHOLAR ROCK HOLDING CORP (NASDAQ:SRRK) - ChartMill
103,191 Shares in Scholar Rock Holding Corporation $SRRK Bought by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Biotech Scholar Rock to webcast Jefferies healthcare talk June 3 - Stock Titan
Three Biotechs That Are Top Takeover Targets - Yahoo Finance
iA Global Asset Management Inc. Makes New $5.43 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
Charles Schwab Investment Management Inc. Acquires 25,060 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock reports new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Redmile Group owns 7.6% of Scholar Rock (SRRK) via funds and affiliates - Stock Titan
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
T. Rowe Price holds 5.4% of Scholar Rock (NASDAQ: SRRK) - Stock Titan
Earnings call transcript: Scholar Rock Q1 2026 sees EPS miss, stock rises - Investing.com Nigeria
Earnings call transcript: Scholar Rock Q1 2026 sees EPS miss, stock rises By Investing.com - Investing.com South Africa
Transcript : Scholar Rock Holding Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 08 - marketscreener.com
HC Wainwright Has Positive View of Scholar Rock Q2 Earnings - MarketBeat
A Look At Scholar Rock (SRRK) Valuation After FDA Acceptance Of Apitegromab BLA - Sahm
State of New Jersey Common Pension Fund D Buys New Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
TradingKey - TradingKey
Number of shareholders of Scholar Rock Holding Corp. – FWB:2QK - TradingView
FY2029 EPS Estimates for Scholar Rock Increased by Analyst - MarketBeat
Scholar Rock (SRRK) Q1 2026 Earnings Transcript - AOL.com
Nan Fung Trinity HK Ltd. Buys 225,603 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
Vanguard Group Inc. Boosts Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q1 2026 Earnings Call Transcript - Insider Monkey
Scholar Rock Q1 Earnings Call Highlights - MarketBeat
Scholar Rock (NASDAQ:SRRK) Issues Quarterly Earnings Results - MarketBeat
SRRK Maintained by Barclays -- Price Target Raised to $55 - GuruFocus
Scholar Rock anticipates apitegromab approval by September 30 as FDA accepts SMA BLA with two fill-finish sites - MSN
Scholar Rock (SRRK) Receives Positive Catalyst Watch from JPMorg - GuruFocus
SRRK Maintained by HC Wainwright & Co. -- Price Target Raised to $65 - GuruFocus
UBS Group AG Sells 226,355 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
A Look At Scholar Rock (SRRK) Valuation After Strong Multi Year Shareholder Returns - Yahoo Finance
Transcript : Scholar Rock Holding Corporation, Q1 2026 Earnings Call, May 07, 2026 - marketscreener.com
Scholar Rock Q1 2026 Earnings Call Transcript - MarketBeat
Earnings call transcript: Scholar Rock’s Q1 2026 financial resilience amid earnings miss By Investing.com - Investing.com South Africa
Earnings call transcript: Scholar Rock’s Q1 2026 financial resilience amid earnings miss - Investing.com Nigeria
Scholar Rock Advances Apitegromab Toward Potential 2026 Launches - TipRanks
Earnings Flash (SRRK) Scholar Rock Posts Q1 Net Loss $0.83 a Share, vs. FactSet Est of $0.80 Loss - marketscreener.com
Q1 2026 Scholar Rock Holding Corp Earnings Call Transcript - GuruFocus
Scholar Rock (NASDAQ: SRRK) details March 31 2026 quarter - Stock Titan
Scholar Rock (SRRK) boosts cash to $480M as FDA sets apitegromab PDUFA date - Stock Titan
Scholar Rock gets Sept. 30 FDA decision date for SMA drug - Stock Titan
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights - Business Wire
MSN Money - MSN
Scholar Rock faces earnings test as apitegromab approval looms By Investing.com - Investing.com South Africa
Scholar Rock faces earnings test as apitegromab approval looms - Investing.com
Evercore ISI initiates Scholar Rock stock coverage with outperform rating By Investing.com - Investing.com Australia
2.25%
0.46%
자본화:
|
볼륨(24시간):